Tudor Investment Corp’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-53,466
| Closed | -$420K | – | 2116 |
|
|
2025
Q1 | $420K | Buy |
53,466
+10,498
| +24% | +$82.4K | ﹤0.01% | 1259 |
|
|
2024
Q4 | $640K | Sell |
42,968
-2,682
| -6% | -$39.9K | ﹤0.01% | 1146 |
|
|
2024
Q3 | $698K | Buy |
+45,650
| New | +$698K | ﹤0.01% | 1127 |
|
|
2023
Q4 | – | Sell |
-28,173
| Closed | -$506K | – | 1866 |
|
|
2023
Q3 | $506K | Buy |
+28,173
| New | +$506K | 0.01% | 1115 |
|
|
2021
Q4 | – | Sell |
-41,200
| Closed | -$1.44M | – | 1971 |
|
|
2021
Q3 | $1.44M | Sell |
41,200
-12,857
| -24% | -$448K | 0.02% | 732 |
|
|
2021
Q2 | $1.48M | Buy |
54,057
+46,796
| +644% | +$1.28M | 0.03% | 653 |
|
|
2021
Q1 | $204K | Sell |
7,261
-28,296
| -80% | -$795K | ﹤0.01% | 1410 |
|
|
2020
Q4 | $923K | Buy |
+35,557
| New | +$923K | 0.03% | 709 |
|
|
2020
Q3 | – | Sell |
-66,529
| Closed | -$1.65M | – | 1487 |
|
|
2020
Q2 | $1.65M | Buy |
+66,529
| New | +$1.65M | 0.08% | 302 |
|
|
2020
Q1 | – | Sell |
-13,423
| Closed | -$136K | – | 1267 |
|
|
2019
Q4 | $136K | Buy |
+13,423
| New | +$136K | 0.01% | 1030 |
|
|
2018
Q2 | – | Sell |
-27,723
| Closed | -$428K | – | 1182 |
|
|
2018
Q1 | $428K | Buy |
+27,723
| New | +$428K | 0.01% | 608 |
|